Similar companies
Did Krystal Biotech Beat Earnings?
Krystal Biotech (KRYS) reported Q2 '26 revenue of $119M, up 24.1% year-over-year, with reported EPS of $1.79. That topped the $1.70 analyst estimate by 5.3% — an earnings beat.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Krystal Biotech’s job postings, web traffic, and employee business outlook. See the full KRYS stock analysis or the earnings calendar for upcoming reports.
KRYS Earnings Surprise History (EPS vs. Estimate)
| Quarter | Estimated EPS | Reported EPS | Surprise |
|---|---|---|---|
| Q2 '26 | $1.70 | $1.79 | Beat +5.3% |
| Q1 '26 | $1.42 | $1.83 | Beat +28.9% |
| Q4 '25 | $1.58 | $1.70 | Beat +7.6% |
| Q3 '25 | $1.12 | $2.66 | Beat +137.5% |
| Q2 '25 | $1.44 | $1.29 | Missed -10.4% |
| Q1 '25 | $1.52 | $1.20 | Missed -21.1% |
Krystal Biotech Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 84M | 91M | 88M | 96M | 98M | 107M | 116M | 119M |
| Gross margin | 92.0% | 94.6% | 94.3% | 92.5% | 94.2% | 89.8% | 94.6% | 94.6% |
| Operating margin | 26.8% | 45.4% | 41.0% | 40.9% | 42.3% | 41.5% | 46.1% | 49.0% |
| Net income | 27M | 45M | 36M | 38M | 79M | 51M | 56M | 55M |
| Net margin | 32.4% | 49.9% | 40.5% | 39.9% | 81.2% | 48.0% | 48.1% | 45.9% |
| EPS | $0.91 | $1.53 | $1.20 | $1.29 | $2.66 | $1.70 | $1.83 | $1.79 |
Krystal Biotech Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Krystal Biotech’s quarterly revenue moved from $84M to $119M. Net margin expanded from 32.4% to 45.9%, against a 94.6% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. Krystal Biotech has beaten Wall Street EPS estimates in 5 of its last 8 reported quarters.
When Is Krystal Biotech’s Next Earnings Date?
Krystal Biotech reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the KRYS earnings calendar.
Frequently Asked Questions: Krystal Biotech Earnings
Krystal Biotech's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Krystal Biotech reported Q2 '26 EPS of $1.79 on revenue of $119M (+24.1% YoY). Krystal Biotech beat estimates, reporting $1.79 vs. the $1.70 estimate.
Krystal Biotech reported Q2 '26 revenue of $119M, up 24.1% from the same quarter a year earlier.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the KRYS AI Score.
